Loratadine's Heir Apparent Available for Allergy Season Drugs Similar, But Not the Same Agent Performed Well in Trials Agent May Prove as Profitable as Loratadine ...

Facing a patent expiration in December for its top-selling Claritin (loratadine) product and beset recently by quality concerns, Schering needs to market a winner. Will desloratadine's approval ...

Morepen Laboratories rallied 3.95% to Rs 51.87 after the board of directors of Dr. Morepen (DML), a wholly owned subsidiary of the company has approved the formation of a new subsidiary on 19 February ...